Abstract
House dust mite-specific IgE, IgG and IgG subclass antibody responses were evaluated during immunotherapy in perennial allergic rhinitis patients. It was found that IgG4 antibodies steadily increased during treatment, while IgG and IgG1 antibodies reached a plateau 6 months after the initiation of immunotherapy. IgE antibodies also increased during treatment. It was also found that the good clinical outcome was associated with the rate of increase of IgG4 antibodies, but not with IgG, IgG1 or IgE antibodies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International archives of allergy and applied immunology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.